ID: ALA2086636

Max Phase: Preclinical

Molecular Formula: C13H11BrClN3O2

Molecular Weight: 356.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(COc1ccc(Cl)cc1Br)N/N=C/c1ccc[nH]1

Standard InChI:  InChI=1S/C13H11BrClN3O2/c14-11-6-9(15)3-4-12(11)20-8-13(19)18-17-7-10-2-1-5-16-10/h1-7,16H,8H2,(H,18,19)/b17-7+

Standard InChI Key:  FHVATFUHFRZYLT-REZTVBANSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.61Molecular Weight (Monoisotopic): 354.9723AlogP: 2.96#Rotatable Bonds: 5
Polar Surface Area: 66.48Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.53CX Basic pKa: 0.50CX LogP: 3.00CX LogD: 3.00
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.64Np Likeness Score: -1.97

References

1. Germain AR, Carmody LC, Morgan B, Fernandez C, Forbeck E, Lewis TA, Nag PP, Ting A, VerPlank L, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B..  (2012)  Identification of a selective small molecule inhibitor of breast cancer stem cells.,  22  (10): [PMID:22503247] [10.1016/j.bmcl.2012.01.035]

Source